Intent Required To Show Suppression And Inequitable Conduct
Client Alert | 1 min read | 07.19.06
In Flex-Rest, LLC v. Steelcase, Inc . (No. 05-1354, -1367; July 13, 2006), a Federal Circuit panel affirms a jury verdict of invalidity of one Flex-Rest patent and a grant of summary judgment that Steelcase did not infringe another Flex-Rest patent, both patents relating to computer keyboard positioning systems. It also affirms the district court's denial of Steelcase's motion for a determination of inequitable conduct in procuring the patent found to be invalid.
In the district court, Flex-Rest argued that Steelcase's KBS device did not qualify as prior art because it had suppressed or concealed the invention of that device. Steelcase's patent application was filed about six and one-half months after its reduction to practice, and Steelcase unveiled its KBS device at a trade show at about the same time. This time period between reduction to practice and filing was not considered to be an unreasonable delay, and Flex-Rest was deemed to have failed to provide any evidence of an intent to withhold the KBS device from the public. Thus, insufficient evidence is present to support a jury instruction regarding an inference of suppression or concealment.
With regard to inequitable conduct, the panel considers a letter and photographs from a competitor that were received by Flex-Rest's patent counsel. The letter containing the photographs was dated May 14, 1996, and the photographs, which were undated, were identified in the letter as showing equipment embodied in “the Seiler patent.” Flex-Rest's patent counsel did not consider the photographs to be credible evidence of prior art. Moreover, he considered the photographs to be cumulative of a patent disclosed to the PTO and thus did not disclose them as well. In light of this evidence, the district court is found not to have abused its discretion in finding that Flex-Rest's patent counsel lacked intent to mislead the PTO.
Insights
Client Alert | 6 min read | 10.26.26
Executive Order Creates Women’s Health Task Force, Rescinds Prior Initiatives
On October 19, 2026, President Trump signed an executive order (EO) titled “Advancing Women’s Health to Improve Outcomes in All Phases of Life,” establishing new federal infrastructure dedicated to improving women’s health research, clinical translation, and coordinated policy leadership. The EO creates a White House Women’s Health Task Force and directs the U.S. Department of Health and Human Services (HHS) to establish a new Women’s Health Division within the National Institutes of Health (NIH).
Client Alert | 7 min read | 10.22.26
Africa, MENA, and the Arbitration Act 2025: LCIA’s Latest Report
Client Alert | 4 min read | 10.22.26
CMS Proposal Would Require Extensive Provider Directory Changes in MA
